Mitsubishi Tanabe Pharma Corp - Company Profile
Powered by 
All the data and insights you need on Mitsubishi Tanabe Pharma Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Mitsubishi Tanabe Pharma Corp Strategy Report
- Understand Mitsubishi Tanabe Pharma Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Group Corporation, manufactures and markets pharmaceutical products. The company offers ethical drugs for autoimmune diseases, diabetes and kidney diseases, central nervous system (CNS) disorders and other diseases and vaccines for infectious diseases. It supplies products to pharmaceutical wholesalers, hospitals, clinics, and drugstores. It operates through single reportable segment, pharmaceuticals segment, which undertakes the research, development, manufacture, and sale of ethical drugs (prescription drugs) and over the counter (OTC) pharmaceutical products in Japan and overseas.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s R&D focuses on the enhancing the disease portfolio of existing therapeutics and development of new products. The company’s product pipeline includes candidates for multiple disease conditions such as diabetes mellitus, schizophrenia, Crohn’s disease, nervous systems, cardiovascular systems, Parkinson's disease, myasthenia gravis, spinal cord injury, spinal cord injury, and Solid tumor among others. It also utilizes new discovery technologies in fields of next-generation therapeutic antibodies, nucleic acid drugs, protein pharmaceuticals, gas pharmaceuticals and vaccines. Mitsubishi Tanabe has two research centers in Kanagawa and one in Osaka, Japan.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer